INGN logo

Inogen (INGN) Company Overview

Profile

Full Name:

Inogen, Inc.

Sector:

Healthcare

Country:

United States

IPO:

February 14, 2014

Indexes:

Not included

Description:

Inogen, Inc., a company specializing in medical technologies, primarily develops, manufactures, and sells portable oxygen concentrators. Its oxygen concentrators are used to provide supplemental long-term oxygen therapy for patients suffering from chronic respiratory diseases. The company offers the Inogen One, a portable device that concentrates air around the patient to provide them with their sole source of additional oxygen; Inogen At Home - stationary oxygen concentrators; Inogen Tidal Assist Ventilators, as well as related accessories. The company also rents out its products directly to patients. Inogen, Inc. was founded in 2001 and is headquartered in Goleta, California.

Key Details

Price

$10.80

Annual Revenue

$315.66 M(-16.32% YoY)

Annual EPS

-$4.42(-20.44% YoY)

Annual ROE

-40.80%

Beta

1.41

Events Calendar

Earnings

Next earnings date:

Feb 25, 2025

Recent quarterly earnings:

Nov 7, 2024

Recent annual earnings:

Feb 27, 2024
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

N/A
Splits

Next split:

N/A

Recent split:

N/A

Analyst ratings

Recent major analysts updates

Jan 30, 25 Needham
Hold
Jan 14, 25 Needham
Hold
Nov 8, 24 Needham
Hold
Aug 7, 24 Needham
Hold
May 8, 24 Stifel
Hold
May 8, 24 Needham
Hold
Apr 9, 24 Needham
Hold
Feb 15, 24 William Blair
Outperform
Nov 8, 23 JP Morgan
Underweight
Aug 8, 23 Stifel
Hold

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price

Market cap

Technical

Dividend

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Profit

EPS

ROA & ROE

EBIT & EBITDA

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PB Ratio

PS Ratio

Enterprise value

EV/EBITDA

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Leverage

Risk & Stability

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Equity

Liabilities

Debt

Expenses

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Free CashFlow

CAPEX

Institutional Ownership

Here's Why You Should Add Inogen Stock to Your Portfolio Now
Here's Why You Should Add Inogen Stock to Your Portfolio Now
Here's Why You Should Add Inogen Stock to Your Portfolio Now
INGN
zacks.comFebruary 6, 2025

Expanding product portfolio and high prospects for POC raise optimism for INGN stock.

Inogen Stock May Gain on Deal With Yuwell to Expand Global Reach
Inogen Stock May Gain on Deal With Yuwell to Expand Global Reach
Inogen Stock May Gain on Deal With Yuwell to Expand Global Reach
INGN
zacks.comJanuary 28, 2025

INGN and Yuwell collaborate to expand and enhance Inogen's innovation pipeline through R&D collaboration and accelerate the entry of Inogen's brand into the Chinese market.

Arab Health 2025|Yuwell Medical Announces Strategic Investment and Partnership with Inogen in Respiratory Health
Arab Health 2025|Yuwell Medical Announces Strategic Investment and Partnership with Inogen in Respiratory Health
Arab Health 2025|Yuwell Medical Announces Strategic Investment and Partnership with Inogen in Respiratory Health
INGN
prnewswire.comJanuary 26, 2025

DUBAI, UAE, Jan. 26, 2025 /PRNewswire/ -- On the eve of the Arab Health Exhibition, Yuwell Medical held its 2025 Global Core Partner Conference in Dubai , and announced a strategic investment and partnership with Inogen, a leading U.S. company in respiratory health, highlighting our joint commitment to advancing medical device solutions and deeper collaboration. Speaking at the Yuwell Medical 2025 Global Core Partner Conference, Alex WU, Chairman of Yuwell Medical, stated that as a leading enterprise in China's home medical device industry, Yuwell will rely on internal growth and external mergers and acquisitions to promote internationalisation.

Inogen (INGN) Moves to Strong Buy: Rationale Behind the Upgrade
Inogen (INGN) Moves to Strong Buy: Rationale Behind the Upgrade
Inogen (INGN) Moves to Strong Buy: Rationale Behind the Upgrade
INGN
zacks.comJanuary 24, 2025

Inogen (INGN) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).

Inogen Stock Gains Following Solid Preliminary Q4 Revenues
Inogen Stock Gains Following Solid Preliminary Q4 Revenues
Inogen Stock Gains Following Solid Preliminary Q4 Revenues
INGN
zacks.comJanuary 15, 2025

INGN's revenue growth in the fourth quarter is likely to have been boosted by continued robust adoption of its products.

Inogen Stock Rises as FDA Clears SIMEOX 200 Airway Clearance Device
Inogen Stock Rises as FDA Clears SIMEOX 200 Airway Clearance Device
Inogen Stock Rises as FDA Clears SIMEOX 200 Airway Clearance Device
INGN
zacks.comDecember 31, 2024

INGN announces FDA clearance for the SIMEOX 200 Airway Clearance Device.

Here's Why You Should Retain Inogen Stock in Your Portfolio Now
Here's Why You Should Retain Inogen Stock in Your Portfolio Now
Here's Why You Should Retain Inogen Stock in Your Portfolio Now
INGN
zacks.comDecember 24, 2024

Expanding product portfolio and high prospects for POC raise optimism for INGN stock.

Inogen (INGN) May Find a Bottom Soon, Here's Why You Should Buy the Stock Now
Inogen (INGN) May Find a Bottom Soon, Here's Why You Should Buy the Stock Now
Inogen (INGN) May Find a Bottom Soon, Here's Why You Should Buy the Stock Now
INGN
zacks.comNovember 25, 2024

Inogen (INGN) witnesses a hammer chart pattern, indicating support found by the stock after losing some value lately. This coupled with an upward trend in earnings estimate revisions could mean a trend reversal for the stock in the near term.

INGN Stock Gains Following Q3 Earnings Beat, Adjusted Gross Margin Up
INGN Stock Gains Following Q3 Earnings Beat, Adjusted Gross Margin Up
INGN Stock Gains Following Q3 Earnings Beat, Adjusted Gross Margin Up
INGN
zacks.comNovember 11, 2024

Inogen's overall third-quarter 2024 results continue to gain from higher business-to-business sales.

Inogen, Inc. (INGN) Q3 2024 Earnings Call Transcript
Inogen, Inc. (INGN) Q3 2024 Earnings Call Transcript
Inogen, Inc. (INGN) Q3 2024 Earnings Call Transcript
INGN
seekingalpha.comNovember 9, 2024

Call Start: 17:00 January 1, 0000 5:26 PM ET Inogen, Inc. (NASDAQ:INGN ) Q3 2024 Earnings Conference Call November 7, 2024, 5:00 PM ET Company Participants Ryan Peterson - Investor Relations Kevin Smith - President and CEO Mike Bourque - Chief Financial Officer Conference Call Participants Rohin Patel - JPMorgan Mike Matson - Needham Operator Welcome to Inogen's Third Quarter 2024 Earnings Conference Call. At this time, all participants are in a listen-only mode.

FAQ

  • What is the ticker symbol for Inogen?
  • Does Inogen pay dividends?
  • What sector is Inogen in?
  • What industry is Inogen in?
  • What country is Inogen based in?
  • When did Inogen go public?
  • Is Inogen in the S&P 500?
  • Is Inogen in the NASDAQ 100?
  • Is Inogen in the Dow Jones?
  • When was Inogen's last earnings report?
  • When does Inogen report earnings?
  • Should I buy Inogen stock now?

What is the ticker symbol for Inogen?

The ticker symbol for Inogen is NASDAQ:INGN

Does Inogen pay dividends?

No, Inogen does not pay dividends

What sector is Inogen in?

Inogen is in the Healthcare sector

What industry is Inogen in?

Inogen is in the Medical Devices industry

What country is Inogen based in?

Inogen is headquartered in United States

When did Inogen go public?

Inogen's initial public offering (IPO) was on February 14, 2014

Is Inogen in the S&P 500?

No, Inogen is not included in the S&P 500 index

Is Inogen in the NASDAQ 100?

No, Inogen is not included in the NASDAQ 100 index

Is Inogen in the Dow Jones?

No, Inogen is not included in the Dow Jones index

When was Inogen's last earnings report?

Inogen's most recent earnings report was on Nov 7, 2024

When does Inogen report earnings?

The next expected earnings date for Inogen is Feb 25, 2025

Should I buy Inogen stock now?

As of today, analysts generally recommend a 'Hold' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions